Effective treatment of locally advanced periocular basal cell carcinoma with oral hedgehog pathway inhibitor?

Letter to the editor: Effective treatment of locally advanced periocular basal cell carcinoma with oral hedgehog pathway inhibitor

Graefe s Archive for Clinical and Experimental Ophthalmology ◽

10.1007/s00417-021-05310-0 ◽

2021 ◽

Author(s):

Nilay Yuksel

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Effective Treatment ◽

Basal Cell ◽

Locally Advanced ◽

Hedgehog Pathway ◽

Letter To The Editor ◽

Vismodegib: First-in-Class Hedgehog Pathway Inhibitor for Metastatic or Locally Advanced Basal Cell Carcinoma

Journal of the Advanced Practitioner in Oncology ◽

10.6004/jadpro.2014.5.4.7 ◽

2014 ◽

Vol 5 (4) ◽

Cited By ~ 1

Author(s):

Nancy M. Nix, PharmD, BCPS, BCOP ◽

Olivia Burdine, PharmD ◽

Makeda Walker, PharmD

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Locally Advanced ◽

Hedgehog Pathway ◽

CO14. A pivotal study evaluating efficacy and safety of the hedgehog pathway inhibitor (HPI) vismodegib (GDC-0449) in patients with locally advanced (la) or metastatic (m) basal cell carcinoma (BCC)

Melanoma Research ◽

10.1097/01.cmr.0000399448.65869.b7 ◽

2011 ◽

Vol 21 ◽

pp. e9 ◽

Cited By ~ 8

Author(s):

A. Sekulic ◽

M.R. Migden ◽

A.E. Oro ◽

L. Dirix ◽

K. Lewis ◽

...

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Locally Advanced ◽

Hedgehog Pathway ◽

Efficacy And Safety ◽

Pivotal Study ◽

Acquired resistance to the Hedgehog pathway inhibitor vismodegib due to smoothened mutations in treatment of locally advanced basal cell carcinoma

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2014.08.001 ◽

2014 ◽

Vol 71 (5) ◽

pp. 1005-1008 ◽

Cited By ~ 41

Author(s):

Tjinta Brinkhuizen ◽

Marie G. Reinders ◽

Michel van Geel ◽

Annelot J.L. Hendriksen ◽

Aimée D.C. Paulussen ◽

...

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Locally Advanced ◽

Acquired Resistance ◽

Hedgehog Pathway ◽

Hedgehog Pathway Inhibitor Therapy for Locally Advanced and Metastatic Basal Cell Carcinoma

JAMA Dermatology ◽

10.1001/jamadermatol.2016.0780 ◽

2016 ◽

Vol 152 (7) ◽

pp. 816 ◽

Cited By ~ 53

Author(s):

Audrey A. Jacobsen ◽

Adam S. Aldahan ◽

Olivia B. Hughes ◽

Vidhi V. Shah ◽

John Strasswimmer

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Locally Advanced ◽

Inhibitor Therapy ◽

Hedgehog Pathway ◽

Metastatic Basal Cell Carcinoma ◽

Treatment patterns and outcomes for patients with locally advanced basal cell carcinoma before availability of Hedgehog pathway inhibitors: a retrospective chart review

European Journal of Dermatology ◽

10.1684/ejd.2017.3031 ◽

2017 ◽

Vol 27 (4) ◽

pp. 386-392 ◽

Cited By ~ 3

Author(s):

John T. Lear ◽

Nicole Basset-Seguin ◽

Martin Kaatz ◽

Thomas Jouary ◽

Laurent Mortier ◽

...

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Chart Review ◽

Locally Advanced ◽

Retrospective Chart Review ◽

Treatment Patterns ◽

Hedgehog Pathway ◽

Abstract A44: Predictive biomarkers of efficacy to the hedgehog pathway inhibitor, GDC‐0449, in advanced basal cell carcinoma and medulloblastoma in phase I studies

10.1158/1535-7163.targ-09-a44 ◽

2009 ◽

Author(s):

Robert Yauch ◽

Thomas Januario ◽

Ling Fu ◽

Thomas Holcomb ◽

Jeremy Stinson ◽

...

Keyword(s):

Basal Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Basal Cell ◽

Predictive Biomarkers ◽

Hedgehog Pathway ◽

Phase I Studies ◽

Abstract LB-138: Efficacy data of GDC-0449, a systemic Hedgehog pathway antagonist, in a first-in-human, first-in-class Phase I study with locally advanced, multifocal or metastatic basal cell carcinoma patients

10.1158/1538-7445.am2008-lb-138 ◽

2008 ◽

Cited By ~ 5

Author(s):

Daniel D Von Hoff ◽

Charles M Rudin ◽

Patricia M LoRusso ◽

Mitesh J Borad ◽

Ronald L Korn ◽

...

Keyword(s):

Basal Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Basal Cell ◽

Phase I Study ◽

Locally Advanced ◽

Hedgehog Pathway ◽

Efficacy Data ◽

Metastatic Basal Cell Carcinoma

Characterization and Management of Hedgehog Pathway Inhibitor‐Related Adverse Events in Patients With Advanced Basal Cell Carcinoma

The Oncologist ◽

10.1634/theoncologist.2016-0186 ◽

2016 ◽

Vol 21 (10) ◽

pp. 1218-1229 ◽

Cited By ~ 58

Author(s):

Mario E. Lacouture ◽

Brigitte Dréno ◽

Paolo Antonio Ascierto ◽

Reinhard Dummer ◽

Nicole Basset‐Seguin ◽

...

Keyword(s):

Basal Cell Carcinoma ◽

Adverse Events ◽

Cell Carcinoma ◽

Basal Cell ◽

Hedgehog Pathway ◽

Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2013.09.012 ◽

2014 ◽

Vol 70 (1) ◽

pp. 60-69 ◽

Cited By ~ 106

Author(s):

Anne Lynn S. Chang ◽

James A. Solomon ◽

John D. Hainsworth ◽

Leonard Goldberg ◽

Edward McKenna ◽

...

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Hedgehog Pathway ◽

Expanded Access ◽